Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Building global development strategies for cf therapeutics during a transitional cftr modulator era.
Building global development strategies for cf therapeutics during a transitional cftr modulator era.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 07, 2020
Developing Inhaled Antibiotics in Cystic Fibrosis: Current Challenges and Opportunities.
Journal: Annals of the American Thoracic Society
Published: January 19, 2019
CFTR modulator theratyping: Current status, gaps and future directions.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 12, 2018
The U.S. Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis. Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial.
Journal: Annals of the American Thoracic Society
Published: October 12, 2017
Cystic fibrosis radiographic biomarkers - Commentary.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 07, 2017
Cystic fibrosis biomarker - Commentary.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: November 16, 2016
CF end point commentary.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: June 22, 2016
Tiotropium Respimat Is Effective for the Treatment of Asthma at a Dose Lower Than That for Chronic Obstructive Pulmonary Disease.
Journal: Annals of the American Thoracic Society
Published: December 10, 2015
The risks and benefits of indacaterol--the FDA's review.
Journal: The New England journal of medicine
Published: December 16, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026